ENSC Competitors & Alternatives

Compare Ensysce Biosciences Inc with similar stocks in the same industry

Biotechnology

ENSC

Main Stock
$0.36
-0.17%
Tradestie Score
52
Market Cap
$7.21M
Revenue Growth
-15.1%
Analyst Upside
+1034.3%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: TAAP prodrug, MPAR abuse resistance
Major Customers 2
pharmaceutical partners clinical trial sites
Critical Suppliers 2
CROs API manufacturers
Direct Ecosystem Rivals 2

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
CLYM Climb Bio, Inc. Common Stock
$9.19
-0.97%
$133.50M - 42 Compare
SRZN Surrozen, Inc. Common
$28.46
-7.21%
$117.07M - 34 Compare
ANRO Alto Neuroscience Inc.
$25.37
-4.30%
$110.20M - 44 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.31
+0.76%
$84.52M - 40 Compare
IMMX Immix Biopharma, Inc. Common Stock
$6.96
-1.14%
$67.94M - 48 Compare
PALI Palisade Bio, Inc. Common Stock
$0.84
-9.24%
$12.21M 1.0 38 Compare
BFRI Biofrontera Inc. Common Stock
$0.53
-7.02%
$10.88M - 42 Compare
KTTA Pasithea Therapeutics Corp. Common Stock
$0.48
-0.48%
$5.73M - 40 Compare
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares
$3.28
-2.35%
$4.25M 7.6 44 Compare
PTPI PTPI
- - - - Compare

Data updated: Nov 20, 2026 | Industry: Biotechnology (SIC 2834)

217 stocks in this industry